<DOC>
	<DOCNO>NCT00520949</DOCNO>
	<brief_summary>Triple therapy , combination proton pump inhibitor two antibiotic , gold standard anti-Helicobacter pylorus treatment . Usual antibiotic clarithromycin , either amoxicillin one nitroimidazoles ( metronidazole ) . However , increase evidence H. pylorus resistance classical triple therapy . Another reason failure low patient compliance treatment . A regimen useful one geographical area may effective practical another area . The aim study eradicate H. pylorus infection resistant triple therapy , establish efficacy safety 14-day therapeutic regimen eradicate H. pylorus patient fail classical triple therapy ( omeprazole , clarithromycin amoxicillin ) give 14 day .</brief_summary>
	<brief_title>Quadruple Therapy Triple Therapy Resistant Helicobacter Pylori Infection</brief_title>
	<detailed_description />
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Bismuth tripotassium dicitrate</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Furazolidone</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Informed consent give patient Patients know H. pylori infection diagnose histopathology , rapid urease test urea breath test Failure respond classical triple regime amoxicillin 1gram , clarithromycin 500mg omeprazole 20mg twice day 1014 day document repeat urea breath test do one month eradication therapy Evidence malignancy , gastric outlet syndrome , history gastric surgery , chronic liver disease , severe chronic renal failure , major comorbidity . know suspected hypersensitivity medication use study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>H.pylori</keyword>
	<keyword>Triple therapy failure</keyword>
	<keyword>Quadruple therapy</keyword>
</DOC>